Amundi Pioneer Asset Management Inc. Purchases 4,194 Shares of Clorox Co (NYSE:CLX)

Amundi Pioneer Asset Management Inc. raised its position in shares of Clorox Co (NYSE:CLX) by 1.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 374,868 shares of the company’s stock after acquiring an additional 4,194 shares during the period. Amundi Pioneer Asset Management Inc. owned approximately 0.29% of Clorox worth $60,151,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in CLX. Athena Capital Advisors LLC bought a new position in Clorox in the fourth quarter valued at approximately $25,000. Zions Bancorporation N.A. bought a new position in Clorox in the first quarter valued at approximately $28,000. Northstar Capital Management LLC bought a new position in Clorox in the first quarter valued at approximately $29,000. Capital Financial Planning LLC bought a new position in Clorox in the fourth quarter valued at approximately $32,000. Finally, Paragon Capital Management LLC bought a new position in Clorox in the first quarter valued at approximately $35,000. Institutional investors own 77.55% of the company’s stock.

In related news, SVP Denise Garner sold 20,399 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the completion of the transaction, the senior vice president now directly owns 4,896 shares in the company, valued at approximately $771,658.56. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.40% of the stock is owned by corporate insiders.

NYSE CLX traded down $0.31 during trading on Monday, reaching $152.80. The company’s stock had a trading volume of 1,145,600 shares, compared to its average volume of 1,025,118. The company has a 50 day moving average of $152.28. The stock has a market cap of $19.47 billion, a price-to-earnings ratio of 24.41, a price-to-earnings-growth ratio of 4.46 and a beta of 0.38. The company has a debt-to-equity ratio of 2.93, a current ratio of 1.10 and a quick ratio of 0.66. Clorox Co has a 12 month low of $127.34 and a 12 month high of $167.70.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, May 1st. The company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.03). The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. Clorox’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.37 earnings per share. As a group, research analysts anticipate that Clorox Co will post 6.29 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be given a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a yield of 2.77%. This is a boost from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date of this dividend is Tuesday, July 30th. Clorox’s dividend payout ratio is currently 61.34%.

A number of brokerages have issued reports on CLX. Wells Fargo & Co reaffirmed a “hold” rating and issued a $153.00 price objective on shares of Clorox in a research note on Thursday, May 30th. Citigroup set a $156.00 price objective on shares of Clorox and gave the company a “hold” rating in a research note on Thursday, May 23rd. Argus lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. BMO Capital Markets set a $168.00 target price on shares of Clorox and gave the stock a “buy” rating in a report on Thursday, May 2nd. Finally, Bank of America reiterated a “neutral” rating and issued a $154.00 target price (down from $165.00) on shares of Clorox in a report on Thursday, May 2nd. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. Clorox currently has a consensus rating of “Hold” and a consensus target price of $149.29.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: What is the formula for the cash asset ratio?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.